Financhill
Back

Arrowhead Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50

ARWR
Arrowhead Pharmaceuticals, Inc.

Last Price:
$63.83
Seasonality Move:
16.71%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is relatively stagnant and ARWR is experiencing slight selling pressure.

Arrowhead Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 63.24 Buy
20-day SMA: 66.29 Sell
50-day SMA: 66.8 Sell
200-day SMA: 36.4 Buy
8-day EMA: 64.09 Buy
20-day EMA: 65.2 Sell
50-day EMA: 62.87 Buy
200-day EMA: 43.5 Buy

Arrowhead Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 47.85 Sell
Chaikin Money Flow: -17147 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.23 - 68.97) Sell
Bollinger Bands (100): (39.77 - 67.95) Buy

Arrowhead Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Arrowhead Pharmaceuticals, Inc. Stock

Is Arrowhead Pharmaceuticals, Inc. Stock a Buy?

ARWR Technical Analysis vs Fundamental Analysis

Sell
50
Arrowhead Pharmaceuticals, Inc. (ARWR) is a Sell

Is Arrowhead Pharmaceuticals, Inc. a Buy or a Sell?

Arrowhead Pharmaceuticals, Inc. Stock Info

Market Cap:
9B
Price in USD:
64.38
Share Volume:
1.6M

Arrowhead Pharmaceuticals, Inc. 52-Week Range

52-Week High:
76.76
52-Week Low:
9.57
Sell
50
Arrowhead Pharmaceuticals, Inc. (ARWR) is a Sell

Arrowhead Pharmaceuticals, Inc. Share Price Forecast

Is Arrowhead Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Arrowhead Pharmaceuticals, Inc.

Is Arrowhead Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.10 per share, a decrease this year of $3.21 per share, and a decrease next year of $1.06 per share.

Technical Analysis of Arrowhead Pharmaceuticals, Inc.

Should I short Arrowhead Pharmaceuticals, Inc. stock?

* Arrowhead Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.